GBC Blog

On March 7, 2023, Robert Snyder, PhD, Associate Director of Genomics at Precision for Medicine, delivered a presentation entitled, Biobank Partnering for Clinical Trial Assay / CDx Development and High-throughput IHC & NGS Screening, at the 30th International Molecular Med Tri-Con Conference & Expo. As an end-to-end provider of biospecimens, specialty labs, and regulatory consulting services, Precision for…

SAN FRANCISCO, Feb. 2, 2023 /PRNewswire/ — Qvin™, the biotechnology company that developed the first and only healthcare service that scientifically collects menstrual blood to test for HR-HPV and other critical healthcare information, announced FDA approval in Thailand for its Q-Pad technology. Thailand has a population of 30 million women ages 15 years and older who are at risk of developing cervical…

January 27, 2022 – The Specimen Acquisition Network (SAN) was founded in 2019 when Fred Hutch reached out to academic centers across the Pacific Northwest region, spanning from British Columbia to Portland – leveraging connections through the Cascadia Data Alliance – to increase access to and awareness of available resources, share ideas and foster partnerships,…

Published:November 11, 2021DOI:https://doi.org/10.1016/j.cell.2021.10.015 Highlights Summary There is increasing interest in the potential contribution of the gut microbiome to autism spectrum disorder (ASD). However, previous studies have been underpowered and have not been designed to address potential confounding factors in a comprehensive way. We performed a large autism stool metagenomics study (n = 247) based on participants…

Researchers are hoping to understand whether the microbes in our guts have a role in the disorder. Before Ethan Loyola reached his first birthday, it was clear that something was wrong with his gut. As a baby, he had been given several courses of antibiotics to treat severe ear infections, after which he experienced foul-smelling,…

Every day, millions of Covid-19 tests are performed around the world. Because of the pandemic, everyone is aware of the importance of diagnostic testing. But, as I pointed out earlier, diagnostic tests are necessary for a wide range of conditions that affect all of us, not just pandemic threats. Good clinical care begins with the first…

All crises are not equal, but they all need to be recognised, says Robert Hewitt Robert Hewitt is the founder of Biosample Hub, a new platform that connects biotech companies looking for samples with biobanks that have ethically sourced samples available A dictionary definition of a crisis is a time of great difficulty or danger…

On Friday, September 17, 2021, leadership from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Health Resources and Services Administration (HRSA) signed a Memorandum of Understanding (MOU) to support solutions for early cancer detection and diagnosis to improve patient outcomes, quality of life, and reduce health disparities among medically underserved, geographically isolated,…

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have…

The contract research sector has seen major buyouts and a series of bolt-on deals, and clinical research specialist WCG is the latest to get in on the act as it heads to Wall Street. The nine-year old Princeton, New Jersey-based company, which offers trial help to biopharmas and CROs, made around $500 million last year…